With most brokers still taking a well-earned break, notes are few and far between currently.
In light of this, listed below are a few recent broker recommendations that remain relevant today. Here's why brokers think investors should buy these ASX shares:
CSL Limited (ASX: CSL)
According to a note out of Macquarie, its analysts have an outperform rating and $338.00 price target on this biotherapeutics giant's shares. This follows news that CSL is acquiring Vifor Pharma for $17 billion. Macquarie expects the deal to be earnings per share accretive from FY 2023. The broker also sees opportunities for CSL to scale and grow Vifor's renal business to underpin its longer term growth. The CSL share price was trading at $282.40 on Friday.
Life360 Inc (ASX: 360)
A note out of Morgan Stanley reveals that its analysts have an overweight rating and $16.50 price target on this app maker's shares. According to the note, the broker was pleased with Life360's decision to acquire personal items tracking company Tile for US$205 million (A$282.8 million). It expects the deal to widen the company's target market and offer further cross sell and upsell opportunities. The Life360 share price was fetching $8.35 at the end of the week.
NEXTDC Ltd (ASX: NXT)
Another note out of Macquarie reveals that its analysts have an outperform rating and $16.10 price target on this data centre operator's shares. This follows news that NEXTDC has just acquired its first edge data centre. The new centre is located in Maroochydore on the Sunshine Coast but could be the first of many. Macquarie sees a big opportunity in edge data centres. It notes that these centres service regional areas and have the potential to offer greater returns than current centres in capital cities. The NEXTDC share price was trading at $11.66 at Friday's close.
